Table 3.
Full cohort | |
---|---|
Comorbidity | N = 110,564 |
Elixhauser21extended comorbidity count present at baseline (range 0-31 conditions), median [IQR] | 10.0 [7.0, 13.0] |
Specific Elixhauser components, N(%) | – |
Congestive heart failure | 73,771 (66.7%) |
Cardiac arrhythmias | 69,724 (63.1%) |
Valvular disease | 55,544 (50.2%) |
Peripheral vascular disorders | 38,734 (35.0%) |
Hypertension (any) | 99,569 (90.1%) |
Hypertension, uncomplicated | 98,968 (89.5%) |
Hypertension, complicated | 33,100 (29.9%) |
Paralysis | 4,124 (3.7%) |
Other neurological disorders | 13,307 (12.0%) |
Chronic pulmonary disease | 105,850 (95.7%) |
Diabetes, uncomplicated | 53,250 (48.2%) |
Diabetes, complicated | 32,594 (29.5%) |
Hypothyroidism | 16,388 (14.8%) |
Renal failure | 36,989 (33.5%) |
Liver disease | 17,777 (16.1%) |
Peptic ulcer disease excluding bleeding | 8,701 (7.9%) |
AIDS/HIV | 797 (0.7%) |
Lymphoma | 2,661 (2.4%) |
Metastatic cancer | 4,863 (4.4%) |
Solid tumor without metastasis | 26,869 (24.3%) |
Rheumatoid arthritis/collagen vascular diseases | 39,331 (35.6%) |
Coagulopathy | 19,151 (17.3%) |
Obesity | 47,099 (42.6%) |
Weight loss | 18,373 (16.6%) |
Fluid and electrolyte disorders | 51,534 (46.6%) |
Blood loss anemia | 4,567 (4.1%) |
Deficiency anemia | 24,822 (22.5%) |
Alcohol abuse | 23,078 (20.9%) |
Drug abuse | 16,155 (14.6%) |
Psychoses | 14,642 (13.2%) |
Depression | 48,656 (44.0%) |
Selected comorbidities (ever documented), N(%) | |
Left heart disease | 86,444 (78.2%) |
Diabetes | 61,309 (55.5%) |
COPD | 72,501 (65.6%) |
Interstitial lung disease | 13,032 (11.8%) |
HIV | 861 (0.8%) |
Liver cirrhosis | 21,307 (19.3%) |
Chronic kidney disease | 63,033 (57.0%) |
Connective tissue disease | 8,117 (7.3%) |
Abbreviations same as in Table 2.